Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism

Key facts

Who runs it
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Where
Bologna, ItalySee the site
Trial code
Status
Recruiting
People taking part
120 people, planned
Started
8 Apr 2024
Expected to end
8 Oct 2031
Type of study
Observational
Record updated
12 March 2026

Who can take part

Age
Up to 11 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Newborn screening test positivity for Congenital Hypothyroidism; Subjects born in Emilia-Romagna region, Italy, and undergoing diagnostic confirmation and initiation of replacement therapy; Diagnosis-confirmed subjects who underwent L-T4 replacement therapy in the first month of life at Center for Endocrine-Metabolic Diseases, Pediatrics Units of the IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S.Orsola, Italy; Age ≤11 years old; Obtaining informed consent from parents and/or legal guardians and assent from minors included in the study

Who cannot take part

  • Known chromosomal abnormalities or complex syndromes; Patients transferred to another center before completion of at least one year of follow-up from the start of therapy; Patients who started therapy at another center

Where in Italy

  • IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, ItalyContact: Rita Ortolano, MDTaking people

About the trial

What the trial wants to find out

Observational, retrospective, prospective, pharmacological, single-centre, non-profit study.

Read full original descriptionShow less

The aim is to evaluate, in newborns diagnosed with Congenital Hypothyroidism, the medium- and long-term efficacy and safety of the new formulation of levothyroxine in oral solution, compared to the liquid drop formulation and the tablet formulation.

The study will involve male and female patients referred to the Neonatal Screening Centre at the Centre for Endocrine-Metabolic Diseases of the Paediatrics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola, Italy, who tested positive for Congenital Hypothyroidism.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
12 March 2026